Advances in macrocyclic peptide-based antibiotics

Bioorg Med Chem. 2018 Jun 1;26(10):2850-2858. doi: 10.1016/j.bmc.2017.08.006. Epub 2017 Aug 19.

Abstract

Macrocyclic peptide-based natural products have provided powerful new antibiotic drugs, drug candidates, and scaffolds for medicinal chemists as a source of inspiration to design novel antibiotics. While most of those natural products are active mainly against Gram-positive pathogens, novel macrocyclic peptide-based compounds have recently been described, which exhibit potent and specific activity against some of the most problematic Gram-negative ESKAPE pathogens. This mini-review gives an up-date on recent developments.

Keywords: Antibiotics; Gram-negative ESKAPE pathogens; Macrocyclic peptides and depsipetides; Outer-membrane protein targeting antibiotics (OMPTA).

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Bacteria / drug effects
  • Bacterial Infections / drug therapy
  • Bacterial Outer Membrane Proteins / metabolism
  • Clinical Trials as Topic
  • Depsipeptides / chemistry
  • Depsipeptides / pharmacology
  • Depsipeptides / therapeutic use
  • Drug Discovery / methods*
  • Humans
  • Macrocyclic Compounds / chemistry*
  • Macrocyclic Compounds / pharmacology*
  • Macrocyclic Compounds / therapeutic use
  • Models, Molecular
  • Peptides, Cyclic / chemistry*
  • Peptides, Cyclic / pharmacology*
  • Peptides, Cyclic / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Bacterial Outer Membrane Proteins
  • Depsipeptides
  • Macrocyclic Compounds
  • Peptides, Cyclic